ARKG vs VHT

ARK Genomic Revolution ETF vs Vanguard Health Care ETF

Quick take
  • • VHT has the lower expense ratio at 0.09% vs 0.75% for ARKG.
  • • VHT pays a higher dividend yield (1.35%).

Side-by-side metrics

MetricARKGVHT
Expense ratio
Annual fee. Lower is better.
0.75%0.09%
Dividend yield
Trailing 12-month yield.
0.00%1.35%
AUM
Assets under management — bigger funds are typically more liquid.
$2.21B$23.73B
YTD return
66.55%22.17%
1-year return
——
3-year return
Annualized.
——
5-year return
Annualized.
——
10-year return
Annualized.
——
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
2.110.46
P/E ratio
—32.41
Last price
$47.17$347.68
Inception
——
Issuer
ARKVanguard

ARKG top holdings

Top holdings · ARKG
TWSTTwist Bioscience Corp8.75%
TXG10x Genomics Inc Ordinary Shares - Class A8.73%
TEMTempus AI Inc Class A common stock8.36%
ABSIAbsci Corp5.56%
CRSPCRISPR Therapeutics AG5.22%
GHGuardant Health Inc4.88%
NTRANatera Inc4.71%
ILMNIllumina Inc4.69%
LLYEli Lilly and Co3.92%
BEAMBeam Therapeutics Inc3.69%
Sector breakdown · ARKG
Healthcare100.0%

VHT top holdings

Top holdings · VHT
LLYEli Lilly and Co12.93%
JNJJohnson & Johnson8.78%
ABBVAbbVie Inc6.45%
MRKMerck & Co Inc5.01%
UNHUnitedHealth Group Inc4.65%
TMOThermo Fisher Scientific Inc3.50%
AMGNAmgen Inc3.18%
GILDGilead Sciences Inc2.58%
ABTAbbott Laboratories2.40%
PFEPfizer Inc2.27%
Sector breakdown · VHT
Technology0.0%
Financial Services0.0%
Industrials0.0%
Healthcare100.0%

About ARKG

ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $2.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 8.7% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.

About VHT

VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $23.7B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.35%. Its largest holding is Eli Lilly and Co (LLY), which represents 12.9% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.